Salus Group has acquired an interest in Farmadent d.o.o., enhancing its position in the Southeast European healthcare market.

Information on the Target

Farmadent d.o.o. is a prominent wholesale company in Slovenia, specializing in pharmaceuticals, medical supplies, and logistical support for the healthcare sector. With projected revenues exceeding 60 million EUR in 2024, Farmadent plays a crucial role in the distribution of essential healthcare products in the region.

The company is known for its commitment to quality and efficiency in serving healthcare providers, ensuring that medical professionals have access to the necessary resources to deliver effective patient care.

Industry Overview in Slovenia

The healthcare industry in Slovenia has been experiencing significant growth, driven by an increasing demand for medical products and services. With a strong e

View Source

Similar Deals

Bambu Ventures Lemonaid Health

2026

Buyout Advanced Medical Equipment & Technology (NEC) United States of America
OMERS Private Equity CBI Home Health

2026

Buyout Home Healthcare Services Canada
メディアスホールディングス 共栄医科器械

2026

Buyout Medical Equipment, Supplies & Distribution (NEC) Japan
easyJet Adria Tehnika

2026

Buyout Aerospace & Defense (NEC) Slovenia
XenoTherapeutics, Inc. Repare Therapeutics Inc.

2026

Buyout Bio Therapeutic Drugs Canada
ADR120S アスリートメッド

2026

Buyout Hospitals, Clinics & Primary Care Services Japan

Salus

invested in

Farmadent d.o.o.

in 2025

in a Buyout deal

Disclosed details

Revenue: $64M

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert